Cargando…
Using telehealth to improve buprenorphine access during and after COVID-19: A rapid response initiative in Rhode Island
Despite its proven efficacy, buprenorphine remains dramatically underutilized for management of opioid use disorder largely due to onerous barriers to treatment initiation. During the COVID-19 pandemic, many substance use disorder treatment facilities have reduced their hours and services, exacerbat...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817486/ https://www.ncbi.nlm.nih.gov/pubmed/33771282 http://dx.doi.org/10.1016/j.jsat.2021.108283 |